OMEPRAZOLE

• tagApproval110 co-mentions · 54 sources
• drugomeprazole DR63 co-mentions · 57 sources
• drugOMEPRAZOLE AND SODIUM BICARBONATE63 co-mentions · 57 sources
• drugomeprazole XR-ODT63 co-mentions · 57 sources
• tagSmall Molecule55 co-mentions · 54 sources
• companyDexcel Pharma Ltd27 co-mentions · 27 sources
• drug(omeprazole + sodium bicarbonate)16 co-mentions · 16 sources
• tagRecall5 co-mentions · 3 sources

Trials studying OMEPRAZOLE

• phase1A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancerrecruitingn=136
• phase3A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapyactive not recruitingn=420
• phase1A Multiple Dose Study of LY3502970 in Healthy Participantscompletedn=26
• phase1An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substratescompletedn=23
• phase1A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjectscompletedn=40
• phase1Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxincompletedn=13
• phase1Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participantscompletedn=30
• phase1Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)recruitingn=134